Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
11.20 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.20 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.50 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.12 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
10.20 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
10.20 | 11748828 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.17 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.53 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.02 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.98 | 15136595 18357371 19217205 18608205 16595493 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
1.98 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.98 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.53 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
9.42 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
9.42 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
2.12 | 16799960 17088986 17045692 18930000 16332177 17971768 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.18 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.58 | 16280240 16757204 18986760 17066447 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.58 | 18850075 16120746 18670907 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.58 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.25 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.29 | 17725105 15001691 17172411 16510598 17169374 16340194 18772588 17018589 17016597 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 17255274 16524972 18949393 17401013 17594712 17695437 17016601 16303861 18288408 18802399 16391804 16282729 18448328 18509181 15289873 14970324 17094418 18383874 16331619 20501625 15148649 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.85 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.85 | 15322242 10048152 20055451 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.68 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.53 | 16733453 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.71 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.62 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.09 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.85 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.77 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.47 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.53 | 16481741 16337965 15173087 17638652 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.11 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.60 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
3.00 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.46 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.80 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.67 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.53 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.82 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.91 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.03 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.04 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.69 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.63 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.91 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.94 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.89 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.44 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.44 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.53 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.26 | 17352296 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.98 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
6.02 | 17488658 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.38 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.79 | 18600527 16928823 18239605 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.80 | 14600291 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.72 | 16436463 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.78 | 19003803 16500647 15113037 16929163 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
5.12 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.14 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.93 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.34 | 19082440 18626508 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.55 | 17410198 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.43 | 16160472 18286688 18722050 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.36 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.42 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.21 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 18396642 17498489 17522103 15786421 16424979 16951190 19084572 18567086 17172411 19015929 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.62 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.77 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.44 | 16280240 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.33 | 16803524 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.46 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
5.12 | 15886252 |